Montre
al, Canada… Lallemand Health Solutions is pleased to announce that its specific probiotic strain Lactobacillus helveticus Lafti® L10 has been selected as a finalist in this year’s NutraIngredients Awards for the Ingredient of the Year in the Immunity category. Final Awards announcement will be made during Vitafoods Europe, May 9-11 in Geneva.
The probiotic Lactobacillus helveticus Lafti® L10 is supported by several clinical studies showing its immune support benefits. These include the most recent one conducted on elite athletes (Marinkovic et al., 2016) indicating the probiotic efficacy to shorten upper respiratory tract infections episodes by 3.4 days and reduce significantly the number of symptoms per episode in training athletes by 29%, which has been correlated to the significant improvement of immune markers in blood. These studies are backed by further in vitro and in vivo evidences of the probiotic modes of action and immunomodulating effects.
Visitors to Vitafoods Europe will be able to discover Lactobacillus helveticus Lafti® L10 on Lallemand Health Solutions Booth G42 as part of our Active People and Immunity ranges of complete probiotic solutions, along with our specifically designed offers for the Brain-Gut Axis, Hearty Kids, Gut Health, Oral Health, Women’s Health and Immunity.
For more information on the NutraIngredients Awards visit: http://www.nutraingredients-awards.com/
Marinkovic, D. M. (2016). “Lactobacillus helveticus Lafti® L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized double-blind placebo-controlled trial.” Applied Physiology, Nutrition, and Metabolism.
Contact: Media Relations:
Bérengère Feuz Sylvie Roquefeuil
Marketing Group Manager Press Officer
Tel.: +33 (0)5 62 74 5555 Tel.: +33 (0) 6 84 72 76 10
Email: healthsolutions@lallemand.com Email: sroquefeuil@lallemand.com